NCT04503265: A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 122 planned
- Started
- 12 Aug 2020
- Primary completion
- Aug 2026
- Arms
- AMXI-5001 Treatment
- Results
- None posted
- 7 Aug 2020: Trial registered
- 12 Aug 2020: Trial started